Innate and adaptive antifungal immune responses: Partners on an equal footing

Mycoses

Volumn 55, Issue 3, 2012, Pages 205-217

  Hamad, Mawieh ^a  

^a Research and Development Unit   (Jordan)

Author keywords

Aspergillosis; Candidiasis; Dendritic cells; Pattern recognition receptors; Th17 cytokines

Indexed keywords

ANTIBODY;

ADAPTIVE IMMUNITY; ARTICLE; ASPERGILLOSIS; CELL DIFFERENTIATION; CRYPTOCOCCOSIS; DENDRITIC CELL; FUSARIOSIS; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; INVASIVE CANDIDIASIS; MEDICAL RESEARCH; MUCOCUTANEOUS CANDIDIASIS; NONHUMAN; PRIORITY JOURNAL; TRICHOSPORONOSIS; ZYGOMYCETES;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; FUNGI; HUMANS; IMMUNE TOLERANCE; MYCOSES; T-LYMPHOCYTES, REGULATORY;

EID: 84859971479     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02078.x     Document Type: Article

References (123)

1. Hamad M, Abu Elteen KH. Human fungal infections: basic biology and epidemiology. In: Hamad M, Abu Elteen KH (eds), Immunity and Immunotherapy of Human Fungal Infections. New York: Nova Science Publishers, 2011: 1-30.
2. Bozza S, Clavaud C, Giovannini G et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol 2009; 183: 2407-14.
3. Bonifazi P, Zelante T, D'Angelo C et al. Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. Mucosal Immunol 2009; 2: 362-74.
4. Conti HR, Shen F, Nayyar N et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206: 299-311.
5. Shoham S, Levitz ML. The immune response to fungal infections. Br J Hematol 2005; 129: 569-82.
6. Matthews RC, Burnie JP. Recombinant antibodies: a natural partner in combinatorial antifungal therapy. Vaccine 2004; 2: 865-71.
7. Blanco JL, Garcia ME. Immune response to fungal infections. Vet Immunol Immunopathol 2008; 125: 47-70.
8. Gil ML, Gozalbo D. Role of Toll-like receptors in systemic Candida albicans infections. Front Biosc 2009; 14: 570-82.
9. Schofield DA, Westwater C, Balish E. Divergent chemokine, cytokine and beta-defensin responses to gastric candidiasis in immunocompetent C57BL/6 and BALB/c mice. J Med Microbiol 2005; 54: 87-92.
10. Murciano C, Villamón E, Yáñez A, O'Connor JE, Gozalbo D, Gil ML. Impaired immune response to Candida albicans in aged mice. J Med Microbiol 2006; 55: 1649-56.
11. + T cells in protection against vaginal candidosis. Clin Exp Immunol 2003; 131: 26-33.
12. Al-Sadeq A, Hamad M, Abu-Elteen H. Patterns of expression of vaginal T cell activation markers during estrogen-maintained vaginal candidiasis. Asthma Allergy Clin Immunol 2008; 4: 156-62.
13. Simitsopoulou M, Roilides E, Likartsis C et al. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrob Agents Chemother 2007; 51: 1048-54.
14. Romani L. Immunity to fungi. In: Kavanagh K (ed.), New Insights in Medical Mycology. Dordrecht: Springer Science and Business Media, 2007: 1-19.
15. Bennett JE. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008. J Antimicrob Chemother 2009; 63: i23-i26.
16. Segal B, Leto T, Gallin J, Malech H, Holland S. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 2000; 79: 170-200.
17. Abu Elteen K, Hamad M. Antifungal compounds for use in human therapy. In: Kavanagh K (ed.), Fungi: Biology and Applications, 2nd edn. New York: Wiley & Sons, 2011 (in press).
18. D'Angelo C, De Luca A, Zelante T et al. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. J Immunol 2009; 183: 4609-18.
19. Guhad FA, Jensen HE, Hau J. Complement activation in SCID and nude mice is related to severity of tissue inflammation in the Candida mastitis model. FEMS Microbiol Lett 2000; 192: 27-31.
20. Dei-Cas E, Brun-Pascaud M, Bille-Hansen V, Allaert A, Aliouat EM. Animal models of pneumocystosis. FEMS Immunol Med Microbiol 1998; 22: 163-8.
21. Burger E, Miyaji M, Sano A, Calich VL, Nishimura K, Lenzi HL. Histopathology of paracoccidioidomycotic infection in athymic and euthymic mice: a sequential study. Am J Trop Med Hyg 1996; 55: 235-42.
22. Graybill JR, Najvar LK, Montalbo EM, Barchiesi FJ, Luther MF, Rinaldi MG. Treatment of histoplasmosis with MK-991 (L-743, 872). Antimicrob Agents Chemother 1998; 42: 151-3.
23. Cantorna MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis 1991; 164: 936-43.
24. Salkowski CA, Balish E. Susceptibility of congenitally immunodeficient mice to a nonencapsulated strain of Cryptococcus neoformans. Can J Microbiol 1991; 37: 834-9.
25. Salkowski CA, Balish E. Pathogenesis of Cryptococcus neoformans in congenitally immunodeficient beige athymic mice. Infect Immun 1990; 58: 3300-6.
26. Huffnagle GB, Yates JL, Lipscomb MF. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect Immun 1991; 59: 1423-33.
27. Roths JB, Marshall JD, Allen RD, Carlson GA, Sidman CL. Spontaneous Pneumocystis carinii pneumonia in immunodeficient mutant SCID mice. Natural history and pathobiology. Am J Pathol 1990; 136: 1173-86.
28. Ferwerda B, Ferwerda G, Plantinga TS et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009; 361: 1760-7.
29. Fidel PL. Immunity to Candida. Oral Dis 2002; 8: 69-75.
30. + T cells during Cryptococcus neoformans infection. J Immunol 2005; 174: 7920-8.
31. + cells in resistance to Pneumocystis carinii pneumonia in mice. J Exp Med 1990; 172: 937-45.
32. Phair J, Munoz A, Detels R, Kaslow R, Rinaldo C, Saah A. The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDA Cohort Study Group. N Engl J Med 1990; 322: 161-5.
33. + T-lymphocyte antibodies. Infect Immun 2003; 71: 6292-7.
34. Bozzi A, Reis BS, Goulart MI, Pereira MC, Pedroso EP, Goes AM. Analysis of memory T cells in the human paracoccidioidomycoses before and during chemotherapy treatment. Immunol Lett 2007; 114: 23-30.
35. Bozzi A, Reis BS, Goulart MI, Ampel NM. Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycoses and are not induced by dendritic cells. Infect Immun 2010; 78: 309-15.
36. Liu Y, Yang B, Zhou M et al. Memory IL-22-producing CD4+ T cells specific for Candida albicans are present in humans. Eur J Immunol 2009; 39: 1472-9.
37. Deepe GS Jr, Gibbons RS. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J Infect Dis 2009; 200: 142-51.
38. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999; 37: 397-404.
39. Wüthrich M, Filutowicz HI, Allen HL, Deepe GS, Klein BS. V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis. Infect Immun 2007; 75: 193-200.
40. Jones-Carson J, Vazquez-Torres A, Warner T, Balish E. Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect Immun 2000; 68: 2363-5.
41. Hamad M. The case for extrathymic development of vaginal T lymphocytes. J Reprod Immunol 2008; 77: 109-16.
42. Heninger E, Hogan LH, Karman J et al. Characterization of the Histoplasma capsulatum-induced granuloma. J Immunol 2006; 177: 3303-13.
43. Lindell DM, Ballinger MN, McDonald RA, Toews GB, Huffnagle GB. Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection. Infect Immun 2006; 74: 4538-48.
44. Hamad M, El-Younis EM, Yasin SR, Abu-Elteen KH. TCRVβ clonotypic analysis of vaginal T lymphocytes during experimental vaginal candidiasis in the murine system. Experimental Clin Sci J 2009; 8: 203-10.
45. Felonato M, Pina A, Bernardino S, Loures FV, de Araujo EF, Calich VL. CD28 exerts protective and detrimental effects in a pulmonary model of paracoccidioidomycosis. Infect Immun 2010; 78: 4922-35.
46. Vora S, Purimetla N, Brummer E, Stevens DA. Activity of voriconazole, a new triazole, combined with neutrophils on monocytes against Candida albicans: effect of granulocyte colony-stimulating factor and granulocyte-monocyte colony stimulating factor. Antimicrob Agents Chemother 1998; 42: 907-10.
47. Roilides E, Holmes A, Blake C, Pizzo PA, Walsh TJ. Impairment of neutrophil fungicidal activity against Aspergillus fumigatus in HIV-infected children. J Infect Dis 1993; 167: 905-11.
48. Razonable RR, Henault M, Lee LN et al. Secretion of pro-inflammatory cytokines and chemokines during amphotericin B exposure is mediated by co-activation of Toll-like receptors 1 and 2. Antimicrob Agents Chemother 2005; 49: 1617-21.
49. Brown GD. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011; 29: 1-21.
50. Balish E, Warner TF, Nicholas PJ, Paulling EE, Westwater C, Schofield DA. Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect Immun 2005; 73: 1313-20.
51. Nishikaku AS, Molina RF, Ribeiro LC et al. Nitric oxide participation in granulomatous response induced by Paracoccidioides brasiliensis infection in mice. Med Microbiol Immunol 2009; 198: 123-35.
52. Urban CF, Ermert D, Schmid M et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 2009; 5: e1000639.
53. Jenssen H, Hancock RE. Antimicrobial properties of lactoferrin. Biochimie 2009; 91: 19-29.
54. Puliti M, Radzioch D, Mazzolla R, Barluzzi R, Bistoni F, Blasi E. Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans. Infect Immun 1995; 63: 4170-3.
55. Kim HS, Choi EH, Khan J et al. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun 2005; 73: 3714-24.
56. Szymczak WA, Deepe GS Jr. The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity. J Immunol 2009; 183: 1964-74.
57. Osterholzer JJ, Curtis JL, Polak T et al. CCR2 mediates conventional dendritic cell recruitment and the formation of bronchovascular mononuclear cell infiltrates in the lungs of mice infected with Cryptococcus neoformans. J Immunol 2008; 181: 610-20.
58. Jin X, Qin Q, Tu L, Zhou X, Lin Y, Qu J. Toll-like receptors (TLRs) expression and function in response to inactivate hyphae of Fusarium solani in immortalized human corneal epithelial cells. Mol Vis 2007; 13: 1953-61.
59. Matthews RC. Candida albicans HSP90: link between protective and auto immunity. J Med Microbiol 1992; 36: 367-70.
60. Matthews RC. Pathogenicity determinants of Candida albicans: potential targets for immunotherapy. Microbiology 1994; 104: 1505-11.
61. Alviano DS, Anderson J et al. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. Infect Immun 2004; 72: 229-37.
62. Saylor CA, Dadachova E, Casadevall A. Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors. J Immunol 2010; 184: 336-43.
63. Young M, Macias S, Thomas D, Wormley FL Jr. A proteomic-based approach for the identification of immunodominant Cryptococcus neoformans proteins. Proteomics 2009; 9: 2578-88.
64. van Spriel AB, Sofi M, Gartlan KH et al. The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity. PLoS Pathog 2009; 5: e1000338.
65. + T cells into severe combined immunodeficiency mice. J Clin Investig 1992; 90: 673-8.
66. Roths JB, Sidman CL. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient SCID mice. Infect Immun 1993; 61: 1641-9.
67. Gigliotti F, Haidaris CG, Wright TW, Harmsen AG. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect Immun 2002; 70: 1069-74.
68. Lee LH, Gigliotti F, Wright TW, Simpson-Haidaris PJ, Weinberg GA, Haidaris CG. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 2000; 242: 141-50.
69. Wells J, Gigliotti F, Simpson-Haidaris PJ, Haidaris CG. Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA. Infect Immun 2004; 72: 1548-56.
70. Wells J, Haidaris CG, Wright TW, Gigliotti F. Complement and Fc function are required for optimal antibody prophylaxis against Pneumocystis carinii pneumonia. Infect Immun 2006; 74: 390-3.
71. Ok M, Latgé JP, Baeuerlein C et al. Immune responses of human immature dendritic cells can be modulated by the recombinant Aspergillus fumigatus antigen Aspf1. Clin Vaccine Immunol 2009; 16: 1485-92.
72. Gross O, Poeck H, Bscheider M et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009; 459: 433-6.
73. Loures FV, Pina A, Felonato M, Calich VL. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009; 183: 1279-90.
74. Guo H, Wu X. Innate responses of corneal epithelial cells against Aspergillus fumigatus challenge. FEMS Immunol Med Microbiol 2009; 56: 88-93.
75. Moretti S, Bellocchio S, Bonifazi P et al. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol 2008; 1: 156-68.
76. van de Veerdonk FL, Netea MG, Jansen TJ et al. Redundant role of TLR9 for anti-Candida host defense. Immunobiology 2008; 213: 613-20.
77. Ferwerda G, Netea MG, Joosten LA, van der Meer JW, Romani L, Kullberg BJ. The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine 2010; 28: 614-22.
78. Willment JA, Brown JD. C-type lectin receptors in antifungal immunity. Trends Microbiol 2008; 16: 27-32.
79. Gross O, Gewies A, Finger K et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006; 442: 651-6.
80. Saijo S, Fujikado N, Furuta T et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007; 8: 39-46.
81. Reid DM, Gow NA, Brown GD. Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol 2009; 21: 30-37.
82. Chaung HC, Huang TC, Yu JH, Wu ML, Chung WB. Immunomodulatory effects of beta-glucans on porcine alveolar macrophages and bone marrow haematopoietic cell-derived dendritic cells. Vet Immunol Immunopathol 2009; 131: 147-57.
83. Saijo S, Ikeda S, Yamabe K et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010; 32: 681-91.
84. Wells CA, Salvage-Jones JA, Li X et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 2008; 180: 7404-13.
85. Ruas LP, Bernardes ES, Fermino ML et al. Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS ONE 2009; 4: e4519.
86. d'Ostiani CF, Del Sero G, Bacci A et al. Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 2000; 191: 1661-74.
87. Bozza S, Gaziano R, Spreca A et al. Dendritic cells transport conidia and hyphae of Aspergillus fumigatus from the airways to the draining lymph nodes and initiate disparate Th responses to the fungus. J Immunol 2002; 168: 1362-71.
88. van Bruggen R, Drewniak A, Jansen M et al. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol Immunol 2009; 47: 575-81.
89. Lavigne LM, Albina JE, Reichner JS. Beta-glucan is a fungal determinant for adhesion-dependent human neutrophil functions. J Immunol 2006; 177: 8667-75.
90. Lin JS, Yang CW, Wang DW, Wu-Hsieh BA. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum. J Immunol 2005; 174: 6282-91.
91. Kawai T, Akira S. Toll-like receptor downstream signaling. Arthritis Res Ther 2005; 7: 12-19.
92. Khader SA, Gaffen SL, Kolls JK. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol 2009; 2: 403-11.
93. De Luca A, Zelante T, D'Angelo C et al. IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 2010; 3: 361-73.
94. Kleinschek MA, Müller U, Schütze N et al. Administration of IL-23 engages innate and adaptive immune mechanisms during fungal infection. Int Immunol 2010; 22: 81-90.
95. Curtis MM, Way SS. Interleukin-17 in host defense against bacterial, mycobacterial and fungal pathogens. Immunology 2009; 126: 177-85.
96. Zelante T, De Luca A, D'Angelo C, Moretti S, Romani L. IL-17/Th17 in anti-fungal immunity: what's new? Eur J Immunol 2009; 39: 645-8.
97. Stumhofer JS, Silver J, Hunter CA. Negative regulation of Th17 responses. Semin Immunol 2007; 19: 394-9.
98. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005; 5: 521-31.
99. Chamilos G, Ganguly D, Lande R et al. Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of T(H)-17 responses. PLoS ONE 2010; 5: e12955.
100. Peck A, Mellins ED. Precarious balance: Th17 cells in host defense. Infect Immun 2010; 78: 32-38.
101. Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 2010; 185: 5453-62.
102. Romani L, Zelante T, De Luca A, Fallarino F, Puccetti P. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008; 180: 5157-62.
103. Werner JL, Metz AE, Horn D et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009; 182: 4938-46.
104. Lilic D, Gravenor I, Robson N et al. Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis. Infect Immun 2003; 71: 5690-9.
105. Hu T, Takamoto M, Hida S, Tagawa Y, Sugane K. IFN-gamma deficiency worsens Pneumocystis pneumonia with Th17 development in nude mice. Immunol Lett 2009; 127: 55-59.
106. Zelante T, De Luca A, Bonifazi P et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007; 37: 2695-706.
107. Romani L, Puccetti P. Immune regulation and tolerance to fungi in the lungs and skin. Chem Immunol Allergy 2008; 94: 124-37.
108. McGeachy MJ, Bak-Jensen KS, Chen Y et al. TGF- and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology. Nat Immunol 2007; 8: 1390-7.
109. Rivera A, Collins N, Stephan MT, Lipuma L, Leiner I, Pamer EG. Aberrant tissue localization of fungus-specific CD4+ T cells in IL-10-deficient mice. J Immunol 2009; 183: 631-41.
110. Tavares D, Ferreira P, Arala-Chaves M. Increased resistance to systemic candidiasis in athymic or interleukin-10-depleted mice. J Infect Dis 2000; 182: 266-73.
111. Cenci E, Mencacci A, Casagrande A, Mosci P, Bistoni F, Romani L. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis 2001; 184: 610-7.
112. Livonesi MC, Souto JT, Campanelli AP et al. Deficiency of IL-12p40 subunit determines severe paracoccidioidomycosis in mice. Med Mycol 2008; 46: 637-46.
113. Balish E. A URA3 null mutant of Candida albicans (CAI-4) causes oro-oesophageal and gastric candidiasis and is lethal for gnotobiotic, transgenic mice (Tgepsilon26) that are deficient in both natural killer and T cells. J Med Microbiol 2009; 58(Pt 3): 290-5.
114. Balish E, Wagner RD, Vazquez-Torres A, Jones-Carson J, Pierson C, Warner T. Mucosal and systemic candidiasis in IL-8Rh-/- BALB/c mice. J Leukoc Biol 1999; 66: 144-50.
115. Mershon KL, Vasuthasawat A, Lawson GW, Morrison SL, Beenhouwer DO. Role of complement in protection against Cryptococcus gattii infection. Infect Immun 2009; 77: 1061-70.
116. Held K, Thiel S, Loos M, Petry F. Increased susceptibility of complement factor B/C2 double knockout mice and mannan-binding lectin knockout mice to systemic infection with Candida albicans. Mol Immunol 2008; 45: 3934-41.
117. Hernandez-Novoa B, Bishop L, Logun C et al. Immune responses to Pneumocystis murina are robust in healthy mice but largely absent in CD40 ligand-deficient mice. J Leukoc Biol 2008; 84: 420-30.
118. Basu S, Quilici C, Zhang HH, Grail D, Dunn AR. Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans. Growth Factors 2008; 26: 23-34.
119. Biondo C, Midiri A, Gambuzza M et al. IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type 1 pattern during experimental cryptococcosis. J Immunol 2008; 181: 566-73.
120. Livonesi MC, Rossi MA, de Souto JT et al. Inducible nitric oxide synthase-deficient mice show exacerbated inflammatory process and high production of both Th1 and Th2 cytokines during paracoccidioidomycosis. Microbes Infect 2009; 11: 123-32.
121. Sassá MF, Saturi AE, Souza LF, Ribeiro LC, Sgarbi DB, Carlos IZ. Response of macrophage Toll-like receptor 4 to a Sporothrix schenckii lipid extract during experimental sporotrichosis. Immunology 2009; 128: 301-9.
122. Bretz C, Gersuk G, Knoblaugh S et al. MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus. Infect Immun 2008; 76: 952-8.
123. Greenblatt MB, Aliprantis A, Hu B, Glimcher LH. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med 2010; 207: 923-31.